Effect of Surface-Modified Paclitaxel Nanowires on U937 Cells In Vitro: A Novel Drug Delivery Vehicle
Figure 3
Vials containing paclitaxel in 20% H3PO4/0.4% SDS. (a) 580 g of paclitaxel microcrystals (FT). (b) 580 g of paclitaxel in the form of SM-PNs with 200 nm diameter and 50 m long. (c) 580 g of paclitaxel in the form of SM-PNs with 35 nm diameter and 50 m long. For comparison, note the visibility of the bottom rim of the vial. Each vial contains around 1 mL of 20% H3PO4/0.4% SDS.